Showing results (71-80 of 232) with videos related to
Sort By:
Pageof 24
Biological & Pharmaceutical Bulletin|May 3, 2008
Enhanced experimental tumor metastasis with age in senescence-accelerated mouseKosuke Shimizu, Naomi Kinouchi Shimizu, Tomohiro Asai, et al.Neurochemistry International|August 9, 2007
Hippocampal calcium dyshomeostasis and long-term potentiation in 2-week zinc deficiencyAtsushi Takeda, Kohei Yamada, Haruna Tamano, et al.Biological & Pharmaceutical Bulletin|March 3, 2004
PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapyKanae Ichikawa, Tomoya Hikita, Noriyuki Maeda, et al.Cancer Letters|June 3, 2004
(-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesisSatoru Yamakawa, Tomohiro Asai, Takayuki Uchida, et al.Cancer Science|October 27, 2015
Bauhinia purprea agglutinin-modified liposomes for human prostate cancer treatmentKeisuke Ikemoto, Kosuke Shimizu, Kento Ohashi, et al.Pharmaceutical Research|May 2, 2022
Liposomal Formulation for Oral Delivery of Cyclosporine A: Usefulness as a Semisolid-Dispersion SystemKeiko Minami, Makoto Kataoka, Toshihide Takagi, et al.Biological & Pharmaceutical Bulletin|October 24, 2002
Cancer chemotherapy by liposomal 6-[12-(dimethylamino)ethyl]aminol-3-hydroxy-7H-indeno[2,1-clquinolin-7-one dihydrochloride (TAS-103), a novel anti-cancer agentKosuke Shimizu, Miki Takada, Tomohiro Asai, et al.International Journal of Nanomedicine|February 27, 2013
Liposomes and nanotechnology in drug development: focus on ocular targetsMiki Honda, Tomohiro Asai, Naoto Oku, et al.The Journal of Gene Medicine|October 10, 2013
Polycation liposomes as a vector for potential intracellular delivery of microRNAHidenori Ando, Ayaka Okamoto, Masafumi Yokota, et al.Biological & Pharmaceutical Bulletin|June 26, 2002
Potential usage of liposomal 4beta-aminoalkyl-4'-O-demethyl-4-desoxypodophyllotoxin (TOP-53) for cancer chemotherapyKosuke Shimizu, Miki Takada, Tomohiro Asai, et al.Pageof 24